Top Feature

Apr 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
India's most prominent scientist, Dr R.A. Mashelkar, President of the Global Research Alliance, on delivering medicines profitably but cheaply to low income countries.
Feb 02, 2012
From Pharmaceutical Technology
With the $12-billion valued Indian pharma industry expected to grow at a CAGR of 16%, the Indian government plans to capitalize on the growth potential in an effort to beat the competition.
Feb 01, 2012
Pharmaceutical Executive
Sarah Krug asks if it is time for pharma companies to appoint a Chief Patient Officer, a new position designed to build an accord around patient trust.
Aug 01, 2011
Pharmaceutical Executive
What Big Pharma fails to see is how engagement in health policy is the biggest of reputation builders
native1_300x100
lorem ipsum